Načítá se...
Are platelets the primary target of aspirin’s remarkable anti-cancer activity?
Aspirin, when administered at low-doses, has emerged as a powerful anti-cancer drug due to both chemopreventive activity against many forms of cancer and its ability to block metastases when administered post-diagnosis. Platelets, which are often elevated in circulation during the latter stages of c...
Uloženo v:
| Vydáno v: | Cancer Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6679799/ https://ncbi.nlm.nih.gov/pubmed/31300475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-0762 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|